Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / COM
-
Number of holders
-
119
-
Total shares
-
81.1M
-
Shares change
-
+1.6M
-
Total reported value, excl. options
-
$456M
-
Value change
-
+$8.97M
-
Put/Call ratio
-
0.87
-
Number of buys
-
3
-
Number of sells
-
-2
-
Price
-
$5.63
Significant Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q4 2013
133 filings reported holding OREX - OREXIGEN THERAPEUTICS INC - COM as of Q4 2013.
OREXIGEN THERAPEUTICS INC - COM (OREX) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.1M shares
.
Largest 10 shareholders include Capital Research Global Investors (12.4M shares), Partner Fund Management, L.P. (5.05M shares), FIRST MANHATTAN CO (4.96M shares), State Street Corp (4.18M shares), SAC Capital Advisors LP (4M shares), BlackRock Fund Advisors (3.91M shares), BANK OF AMERICA CORP /DE/ (3.6M shares), FMR LLC (3.09M shares), BlackRock Institutional Trust Company, N.A. (2.83M shares), and VANGUARD GROUP INC (2.77M shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.